Kenya continues to be assessed as being at high risk of debt distress despite successfully refinancing a $2 billion (Sh258 billion) Eurobond last year.

The announcement that CMC Motors Group will be shutting down has rekindled concerns about the state of Kenya’s business environment.

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

Both sides to carry out feasibility study, Ruto says Kenya also finalising loan with UAE for budget support UAE says Kenya a gateway to East Africa NAIROBI/ABU DHABI, Jan 15 (Reuters ...

The Kenya Ice Lions have made vast strides since the team was founded in 2016 In Nairobi, the average temperature is more than 20C, yet there is one place in Kenya's capital where it does not even ...

The Dutch government is swatting away an online volley of criticism over a planned European country’s royal visit to Kenya. King Willem-Alexander and Queen Máxima of the Netherlands plan to visit ...

Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.

Prominent Tanzanian activist Maria Sarungi Tsehai, who has said she was abducted by armed men in Kenya and released after several hours, has recounted her ordeal. On Monday, she told a press ...

GSK has agreed to buy US biopharmaceutical business IDRx in a deal worth up to $1.15billion (£1billion). Under the agreement, GSK will pay $1billion upfront to acquire the Massachusetts-based ...

In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...